Download this datacard
Overview
Lobbying Costs
600,000€ - 699,999€
Financial year: Jan 2022 - Dec 2022
Lobbyists (Full time equivalent)
2 Fte (4)
Lobbyists with EP accreditation
3
High-level Commission meetings
3
Lobbying Costs over the years
-
Info
Teva Pharmaceuticals Europe BV (Teva)
EU Transparency Register
27116427434-57 First registered on 14 Dec 2011
Goals / Remit
Established in 1901, Teva is a global generic pharmaceuticals leader and one of the top 10 pharmaceutical companies in the world. Headquartered in Israel, Teva operates in 60 countries and has 46,000 employees worldwide, of which more than 54,000 in the European Union.
Teva specializes in development, production and marketing of a wide range of generic and branded products. Teva also covers R&D and innovation, including on specific therapeutic areas such as CNS, pain, migraine and respiratory diseases.Main EU files targeted
Public Health, Industrial and IP Policies, Pricing and Reimbursement Policies, Pharmaceutical legislation, European external trade agenda, European semester, global health, sustainability and green policies.
Address
Head Office
PIET HEINKADE, 107
Amsterdam 1019
NETHERLANDSEU Office
The Library Europe Avenue de Broqueville 40
Brussels 1200
BELGIUMWebsite
-
People
Total lobbyists declared
4
Employment time Lobbyists 75% 1 50% 2 25% 1 Lobbyists (Full time equivalent)
2
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
3 accreditations were / are live (in bold) for the selected state of 03 Dec 2024
Name Start date End Date Josef KUNRT 03 Oct 2024 03 Oct 2025 Veronica ZILLI 03 Oct 2024 03 Oct 2025 Erick TYSSIER 23 Sep 2024 22 Sep 2025 Josef KUNRT 05 Mar 2024 04 Oct 2024 Veronica ZILLI 05 Mar 2024 04 Oct 2024 Erick TYSSIER 05 Mar 2024 04 Oct 2024 Erick TYSSIER 18 Mar 2023 11 Mar 2024 Josef KUNRT 04 Mar 2023 11 Mar 2024 Veronica ZILLI 04 Mar 2023 11 Mar 2024 Erick TYSSIER 06 Oct 2021 06 Oct 2022 Andrea ZANAGLIO 06 Oct 2021 06 Oct 2022 Andrea ZANAGLIO 17 Dec 2019 17 Dec 2020 Erick TYSSIER 17 Dec 2019 17 Dec 2020 Mr Goncalo PINTO MENDES 17 Dec 2019 17 Dec 2020 Andrea ZANAGLIO 29 Nov 2018 01 Dec 2019 Erick TYSSIER 29 Nov 2018 01 Dec 2019 Andrea ZANAGLIO 09 Dec 2017 29 Nov 2018 Erick TYSSIER 09 Dec 2017 29 Nov 2018 Alberto GIUMMARRA 09 Dec 2017 02 May 2018 Andrea ZANAGLIO 08 Dec 2016 07 Dec 2017 Ms Isabel Klinnert Vlachopoulou 08 Dec 2016 07 Dec 2017 Erick TYSSIER 08 Dec 2016 07 Dec 2017 Andrea ZANAGLIO 15 Dec 2015 08 Dec 2016 Ms Isabel Klinnert Vlachopoulou 15 Dec 2015 08 Dec 2016 Erick TYSSIER 15 Dec 2015 08 Dec 2016 Ms Isabel Klinnert Vlachopoulou 13 Dec 2014 11 Dec 2015 Andrea ZANAGLIO 13 Dec 2014 11 Dec 2015 Mrs Isabel Klinnert Vlachopoulou 13 Dec 2014 27 Jan 2015 Erick TYSSIER 17 Apr 2014 16 Apr 2015 Mr Marcel Daniels 12 Nov 2013 17 Apr 2014 Mr Marcel DANIËLS 28 Nov 2012 20 Nov 2013 Mr Marcel DANIËLS 17 Jan 2012 28 Nov 2012 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
Medicines for Europe - https://www.medicinesforeurope.com/
EFPIA - https://www.efpia.eu/about-us/membership/
Within CEFIC :
--> EFCG (European Fine Chemicals Group - a CEFIC group) - https://efcg.cefic.org/
--> APIC (Active Pharmaceuticals Ingredients Committee) - https://www.apic.cefic.org/Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2022 - Dec 2022
Lobbying costs for closed financial year
600,000€ - 699,999€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
600,000€ - 699,999€
Other financial info
Brussels office is composed of 3 people. 1 person spending 75% of their time on policy and advocacy activities and 2 person spending 50% of their time. 1 additional expert from the company spends 25% of her time on activities within the scope of the Register. Financial information includes relevant project costs, the relevant part of trade organisation fees together with our office facilities and other consulting fees.
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
- Sustainability, Quality and Access to healthcare systems
- eHealth / mHealth
- Industrial policy Initiatives
- Trade agreements
- IP measures
- Corporate social responsibility
- Human medicines Regulatory AffairsOther activities
None declared
- Meetings
Meetings
3 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 16 Jun 2021 Location online Subject Supply chains for medicines Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Margaritis Schinas (Vice-President)
- Maria Luisa Llano Cardenal (Cabinet member)
Other Lobbyists -
Date 20 Oct 2020 Location Videoconference Subject Production capacity of generic medicines in the EU Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Eszter Batta (Cabinet member)
- Thierry Breton (Commissioner)
Other Lobbyists -
Date 28 Mar 2019 Location Brussels Subject Developments in the field of digital health Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
- Meetings